EW Financial Facts

Basic (in dollars per share): 0.66
Research and development expenses: 113.1M
See Full Income Statement

Other current assets: 66.1M
Total assets: 4.34B
See Full Balance Sheet

Edwards Lifesciences Corp. (EW) Earnings

  |   Expand Research on EW
Next EPS Date 7/23/26 EPS Growth Rate +10.4%
Average EPS % Beat Rate +5.5% Revenue Growth Rate +11.1%
Average % Move 1-Wk after EPS +2.5% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/23/26 Q226 N/A$0.74 N/A N/A$1.7B = N/A N/A
4/23/26 Q126 $0.78$0.73 +$0.05$1.65B$1.6B = Details
2/10/26 Q425 $0.58$0.62 -$0.04$1.57B$1.55B = Details
10/30/25 Q325 $0.67$0.59 +$0.08$1.55B$1.5B = Details
7/24/25 Q225 $0.67$0.62 +$0.05$1.53B$1.49B = Details
4/23/25 Q125 $0.64$0.60 +$0.04$1.41B$1.4B = Details
2/11/25 Q424 $0.59$0.55 +$0.04$1.39B$1.36B = Details
10/24/24 Q324 $0.67$0.66 +$0.01$1.35B$1.57B = Details